Profil
Ajay Madan served as Vice President-Preclinical Development at Neurocrine Biosciences, Inc. from 2013 to 2016.
Prior to that, he was Chief Scientific Officer at XenoTech LLC in 2001-2002.
Currently, he is Vice President-Development at Crinetics Pharmaceuticals, Inc. since 2016.
Dr. Madan received his undergraduate degree from Birla Institute of Technology & Science and his doctorate from the University of Kansas.
Anciens postes connus de Ajay Madan
| Sociétés | Poste | Fin |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2022 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/07/2016 |
XenoTech LLC
XenoTech LLC BiotechnologyHealth Technology Provides drug metabolism and drug interaction studies in preclinical/nonclinical drug development | Corporate Officer/Principal | 01/01/2002 |
Formation de Ajay Madan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Birla Institute of Technology & Science
Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoTech LLC
XenoTech LLC BiotechnologyHealth Technology Provides drug metabolism and drug interaction studies in preclinical/nonclinical drug development | Health Technology |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
















